What Caught Our Attention in the Investment World? – Week of June 21-24, 2022

By Kuldip K. Ambastha In the past trading week, the global beauty company Revlon, Inc. (REV) had mostly positive daily returns except for a price decline of -11.5% per share seen on Thursday, June 23, 2022. Per an announcement dated Thursday, June 16, 2022, Revlon has filed for voluntary Chapter 11 bankruptcy and reorganization for …

What Caught Our Attention in the Investment World? – Week of June 6-10, 2022

By Kuldip K. Ambastha Novavax, Inc. (NVAX), a clinical-stage vaccine company, had its stock price fall by -17.2% per share on Thursday, June 9, 2022. (See past coverage if needed: “What Caught Our Attention in the Investment World? – Week of December 27-31, 2021; By Kuldip K. Ambastha.”) In 1Q2022, earnings per share plus total …

What Caught Our Attention in the Investment World? – Week of May 23-27, 2022

By Kuldip K. Ambastha Snap Inc. (SNAP), a social media technology company with smartphone camera application Snapchat as its flagship offering, had its stock price drop by -43.1% per share on Tuesday, May 24, 2022. (See past coverage if needed: “What Caught Our Attention in the Investment World? – Week of April 20-24, 2020; By …

What Caught Our Attention in the Investment World? – Week of April 25-29, 2022

By Kuldip K. Ambastha The stock of Teladoc Health, Inc. (TDOC), a multinational virtual healthcare and telemedicine company, dropped by -40.2% per share on Thursday, April 28, 2022. (See past coverage if needed: “What Caught Our Attention in the Investment World? – Week of April 26-30, 2021; By Kuldip K. Ambastha.”) Wall Street did not …

What Caught Our Attention in the Investment World? – Week of March 14-18, 2022

By Kuldip K. Ambastha Coupa Software Incorporated (COUP) is a technology company focused on “Business Spend Management.” Coupa had a highly volatile week in the stock market, per the table seen above with two negative daily return days followed by three positive daily return days. Early in the trading week, Coupa disappointed Wall Street with …

What Caught Our Attention in the Investment World? – Week of February 28-March 4, 2022

By Kuldip K. Ambastha The stock of GoodRx Holdings, Inc. (GDRX), a digital healthcare platform operator, dropped by -38.9% for the trading day of Tuesday, March 1, 2022. GoodRx was founded in 2011 and went public in 2020 – thus, the company’s stock has a short history of being publicly traded. The stock price dropped …

What Caught Our Attention in the Investment World? – Week of February 22-25, 2022

By Kuldip K. Ambastha Rivian Automotive, Inc. (RIVN), an American electric vehicle and automotive technology company, was founded in 2009 and went public in 2021. The company’s stock has been volatile since going public, delivering many negative and positive return swings from one trading day to the next. Over the course of the past trading …

What Caught Our Attention in the Investment World? – Week of January 18-21, 2022

By Kuldip K. Ambastha In this past trading week, the technology-heavy NASDAQ Composite Index (^IXIC) posted negative daily returns on all four consecutive trading days. (Monday, January 17, 2022 was not a trading day, due to this day being Martin Luther King Jr. Day.) The NASDAQ Composite Index entered into correction territory, with a correction …

What Caught Our Attention in the Investment World? – Week of January 3-7, 2022

By Kuldip K. Ambastha Sea Limited (SE), a technology company based in Singapore with operations in digital entertainment, e-commerce, and digital financial services, was in the news during the past trading week. The stock of Sea Limited had four negative daily returns plus one positive daily return for the trading week, with a -11.4% loss …

What Caught Our Attention in the Investment World? – Week of December 27-31, 2021

By Kuldip K. Ambastha Novavax, Inc. (NVAX), a clinical-stage vaccine company, had four negative daily returns and one positive daily return for its shares during this past trading week per the table displayed here. Worldwide, the coronavirus pandemic continues to be a serious public health issue, especially through the Delta and Omicron COVID-19 variants. Novavax …